147 related articles for article (PubMed ID: 36975412)
21. Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC).
Ji JH; Song HN; Kim RB; Oh SY; Lim HY; Park JO; Park SH; Kim MJ; Lee SI; Ryou SH; Hwang IG; Jang JS; Kim HJ; Choi JY; Kang JH
Jpn J Clin Oncol; 2015 Mar; 45(3):256-60. PubMed ID: 25628352
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
23. ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma.
Verdaguer H; Saurí T; Acosta DA; Guardiola M; Sierra A; Hernando J; Nuciforo P; Miquel JM; Molero C; Peiró S; Serra-Camprubí Q; Villacampa G; Aguilar S; Vivancos A; Tabernero J; Dienstmann R; Macarulla T
Clin Cancer Res; 2022 Apr; 28(8):1662-1671. PubMed ID: 35042699
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma.
Kim SH; Han DH; Choi GH; Choi JS; Kim KS
Surgery; 2022 Jul; 172(1):177-183. PubMed ID: 35065790
[TBL] [Abstract][Full Text] [Related]
25. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
26. Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients.
Baheti AD; Tirumani SH; Shinagare AB; Rosenthal MH; Hornick JL; Ramaiya NH; Wolpin BM
Abdom Imaging; 2014 Dec; 39(6):1193-201. PubMed ID: 24869789
[TBL] [Abstract][Full Text] [Related]
27. Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma.
Meng ZW; Liu MC; Hong HJ; Du Q; Chen YL
Tumour Biol; 2017 Mar; 39(3):1010428317694319. PubMed ID: 28345461
[TBL] [Abstract][Full Text] [Related]
28. Hepatic arterial infusion of gemcitabine plus oxaliplatin as second-line treatment for locally advanced intrahepatic cholangiocarcinoma: preliminary experience.
Ghiringhelli F; Lorgis V; Vincent J; Ladoire S; Guiu B
Chemotherapy; 2013; 59(5):354-60. PubMed ID: 24821200
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
[TBL] [Abstract][Full Text] [Related]
30. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
Li DY; Zhang HB; Yang N; Quan Y; Yang GS
World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635
[TBL] [Abstract][Full Text] [Related]
31. Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Hamba H; Tanaka H; Kinoshita H
World J Surg; 2001 Jul; 25(7):865-9. PubMed ID: 11572025
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
Kojima T; Umeda Y; Fuji T; Niguma T; Sato D; Endo Y; Sui K; Inagaki M; Oishi M; Ota T; Hioki K; Matsuda T; Aoki H; Hirai R; Kimura M; Yagi T; Fujiwara T
PLoS One; 2020; 15(9):e0238392. PubMed ID: 32881910
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
34. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma.
Omichi K; Cloyd JM; Yamashita S; Tzeng CD; Conrad C; Chun YS; Aloia TA; Vauthey JN
Surgery; 2017 Oct; 162(4):752-765. PubMed ID: 28688518
[TBL] [Abstract][Full Text] [Related]
35. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
Chiu TJ; Chen YJ; Kuo FY; Chen YY
PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
[TBL] [Abstract][Full Text] [Related]
36. Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.
Konstantinidis IT; Groot Koerkamp B; Do RK; Gönen M; Fong Y; Allen PJ; D'Angelica MI; Kingham TP; DeMatteo RP; Klimstra DS; Kemeny NE; Jarnagin WR
Cancer; 2016 Mar; 122(5):758-65. PubMed ID: 26695839
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of the survival of 123 patients with intrahepatic cholangiocarcinoma after surgical resection].
Bi C; Wang LM; An SL; Huang J; Feng RM; Wu F; Rong WQ; Wu JX
Zhonghua Zhong Liu Za Zhi; 2016 Jun; 38(6):466-71. PubMed ID: 27346406
[TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients.
Rimini M; Fabregat-Franco C; Persano M; Burgio V; Bergamo F; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Target Oncol; 2023 Jan; 18(1):139-145. PubMed ID: 36689074
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.
Bagante F; Spolverato G; Merath K; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Koerkamp BG; Guglielmi A; Endo I; Pawlik TM
Surgery; 2019 Dec; 166(6):983-990. PubMed ID: 31326191
[TBL] [Abstract][Full Text] [Related]
40. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
